You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lfg316

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial in Phoenix, Winter Haven, Cleveland (Placebo, LFG316)

Terminated
  • Neovascular Age-related Macular Degeneration
  • Placebo
  • LFG316
  • Phoenix, Arizona
  • +2 more
Dec 11, 2020

Kidney Transplantation Trial in Los Angeles (LFG316, IVIG)

Completed
  • Kidney Transplantation
  • Los Angeles, California
    Novartis Investigative Site
Dec 9, 2020

Neovascular Age-elated Macular Degeneration (Wet AMD), Exudative Macular Degeneration Trial in United States (LFG316, Placebo)

Completed
  • Neovascular Age-elated Macular Degeneration (Wet AMD)
  • Exudative Macular Degeneration
  • LFG316
  • Placebo
  • Tucson, Arizona
  • +6 more
Dec 11, 2020

Geographic Atrophy, Age-related Macular Degeneration Trial in United States (LFG316, Sham, LFG316 Lower dose)

Completed
Has Results
  • Geographic Atrophy
  • Age-related Macular Degeneration
  • LFG316
  • +2 more
  • Phoenix, Arizona
  • +18 more
Dec 9, 2020

Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Panuveitis Trial in United Kingdom, United

Completed
Has Results
  • Non-infectious Intermediate Uveitis
  • +2 more
  • LFG316
  • Conventional Therapy
  • Golden, Colorado
  • +7 more
Dec 9, 2020

Geographic Atrophy Trial (CLG561, LFG316, Sham injection)

Completed
Has Results
  • Geographic Atrophy
  • (no location specified)
May 17, 2019